We are here to help   +49 (0) 2241.255 15 0
  • 0Shopping Cart
  • Product Types
      • Coagulation Proteins
      • Enzymes
      • Cells and Media
      • Cytokines and Chemokines
      • COVID-19 / SARS-CoV-2
      • Molecular Biology
      • Stem Cells / iPSC
      • Adhesion Molecules
      • Tissue Dissociation
      • Matrix Proteins / Bioprinting
      • Gene Editing / CRISPR / TARGATT
  • Brands
  • Company
  • Services
  • Career
  • News
  • Contact
  • Menu Menu
Home |Products|COVID-19 / SARS-CoV-2|Coronavirus 2019 Nucleocapsid (1-419 a.a.), Recombinant

Coronavirus 2019 Nucleocapsid (1-419 a.a.), Recombinant

Cat.-Nr.: CS-C9004

Description

A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019.
The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.
While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
The E.Colie derived recombinant protein contains the Coronavirus 2019 CoV-2 Nucleocapsid Phosphoprotein, Wuhan-Hu-1 strain, amino acids (1-419) having a Mw of 46.4 kDa and fused to 6xHis tag at C-terminal.

  • SUPPLIER:

    CellSystems

  • STATUS:

    In Stock

  • SIZE:

    100 µg

  • Overview

Overview

  • Packaging:other package sizes available on request
  • Donor / Source:Escherichia Coli
  • Formulation:CoV-2 Nucleocapsid phosphoprotein was lyophilized from 20mM Na-carbonate buffer pH-9.2.
  • Amino acid sequence:MSDNGPQNQR NAPRITFGGP SDSTGSNQNG ERSGARSKQR RPQGLPNNTA SWFTALTQHG KED
    LKFPRGQ GVPINTNSSP DDQIGYYRRA TRRIRGGDGK MKDLSPRWYF YYLGTGPEAG LPYGANK DGIIWVATEG ALTPKDHIGT RNPANNAAIV LQLPQGTTLP KGFYAEGSRG GSQASSRSSS RSRNSSRNSTP GSSRGTSPAR MAGNGGDAAL ALLLLDRLN QLESKMSGKG QQQQGQTVTK KSAAEASKKP RQKRTATKAY NVTQAFGRRG PEQTQGNFGD QELIRQGTD YKHWPQIA QFAPSASAF FGMSRIGME VTPSGTWLT YTGAIKLDDKDP NFKDQVILLN KHIDAYKTFPP TEPKKDKKK KADETQALP QRQKKQQTVTL LPAADLDDF SKQLQQSMS SADSTQAHH HHHH

RELATED PRODUCTS


  • Coronavirus 2019 Spike Glycoprotein-S1 (16-685 a.a.), Fc Recombinant

  • Coronavirus 2019 Nucleocapsid Mosaic Recombinant

  • Coronavirus 2019 Nucleocapsid Recombinant

  • Coronavirus 2019 Nucleocapsid (127 a.a.), Recombinant

  • Imprint
  • Privacy policy
Coronavirus 2019 Membrane Envelope, Recombinant Coronavirus 2019 Nucleocapsid (201-419 a.a.) Recombinant
Scroll to top